AG
XBI icon

Appleton Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Appleton Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,643
Closed -$220K – 41
2023
Q2 		$220K Buy
+2,643
New +$221K 0.31% 33
2022
Q3 		– Sell
-3,531
Closed -$262K – 30
2022
Q2 		$262K Buy
+3,531
New +$265K 1.52% 22
2021
Q4 		– Sell
-2,097
Closed -$264K – 58
2021
Q3 		$264K Buy
2,097
+38
+2% +$4.89K 0.23% 42
2021
Q2 		$279K Buy
+2,059
New +$271K 0.21% 48
2021
Q1 		– Sell
-2,101
Closed -$296K – 51
2020
Q4 		$296K Buy
+2,101
New +$269K 0.29% 19
2020
Q3 		– Sell
-3,438
Closed -$385K – 33
2020
Q2 		$385K Buy
+3,438
New +$339K 0.46% 17
2020
Q1 		– Sell
-3,977
Closed -$378K – 27
2019
Q4 		$378K Buy
+3,977
New +$344K 0.48% 24
2019
Q2 		– Sell
-5,022
Closed -$455K – 31
2019
Q1 		$455K Buy
+5,022
New +$427K 0.44% 26
2018
Q4 		– Sell
-9,712
Closed -$931K – 25
2018
Q3 		$931K Buy
9,712
+149
+2% +$14.4K 0.99% 14
2018
Q2 		$910K Buy
9,563
+38
+0.4% +$3.49K 1.2% 12
2018
Q1 		$836K Buy
9,525
+1,286
+16% +$117K 0.96% 15
2017
Q4 		$699K Sell
8,239
-269
-3% -$22.5K 0.69% 21
2017
Q3 		$737K Buy
8,508
+375
+5% +$30.1K 0.79% 18
2017
Q2 		$628K Buy
8,133
+1,585
+24% +$112K 0.71% 18
2017
Q1 		$454K Buy
6,548
+2,580
+65% +$173K 0.52% 21
2016
Q4 		$235K Buy
3,968
+526
+15% +$32.5K 0.31% 26
2016
Q3 		$228K Buy
+3,442
New +$213K 0.28% 27
2015
Q3 		– Sell
-2,472
Closed -$208K – 29
2015
Q2 		$208K Buy
+2,472
New +$192K 0.24% 23

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Appleton Group's XBI Position: Q3 2023 in Review

Appleton Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,643 shares — an estimated $220K sold.

Appleton Group first reported a position in XBI in Q2 2015 and held it in 18 quarters. The position peaked at $931K in Q3 2018. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

  • Appleton Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Appleton Group sold 2,643 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $220K.
  • Appleton Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 18 quarters.
  • Appleton Group's State Street SPDR S&P Biotech ETF position peaked at $931K in Q3 2018.
  • 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Appleton Group's 13F filing for Q3 2023, filed 8 Nov 2023.